Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.3.3 to v3.3.4, with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:49:29.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section listing California and Tennessee study sites; removed the separate California Locations and Tennessee Locations entries. Revision: v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T23:00:32.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New study record dates were added (e.g., 2025-12-05, 2025-12-03) and the primary completion date is listed as 2026-07-01; contemporaneously, earlier date entries (2025-08-26, 2025-08-22, 2025-11-17) were removed.
    Difference
    0.3%
    Check dated 2025-12-09T19:39:29.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision notes were updated to add v3.3.2 and remove v3.2.0, with no visible changes to the study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:29.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The government funding/operating status notice at the top of the page has been removed. The study details, eligibility criteria, and related links remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:25.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The screenshots show minor administrative updates to the study page (such as the last update timestamp and formatting tweaks) with no changes to the core study details, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:28:32.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.